Article

Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of SARS-CoV-2 infectivity

2021-07-30

Abstract excerpt

The pandemic caused by the SARS-CoV-2 has created the need of compounds able to interfere with the biological processes exploited by the virus. Doxycycline, with its pleiotropic effects, including anti-viral activity, has been proposed as a therapeutic candidate for COVID-19 and about twenty clinical trials have started since the beginning of the pandemic. To gain information on the activity of doxycycline against...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bbfb3b88-fd19-5937-bd78-ac44aee9db51
DOI: 10.1101/2021.07.30.454436

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of SARS-CoV-2 infectivityDOI 10.1101/2021.07.30.454436Read

Identification of Potent Small Molecule Inhibitors of SARS-CoV-2 EntrySemantic proximity Read

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism**Semantic proximity Read

Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infectionSemantic proximity Read

Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-viralsSemantic proximity Read

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19Semantic proximity Read

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2Semantic proximity Read

Small-Molecule <i>In Vitro</i> Inhibitors of the Coronavirus Spike – ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2Semantic proximity Read

Inhibitors of SARS-CoV‑2 Entry: Current and Future OpportunitiesSemantic proximity Read

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2Semantic proximity Read

Computational Approach for Covalent Lead Identification against Spike Glycoprotein of SARS-CoV-2Semantic proximity Read

DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.Semantic proximity Read

Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry MechanismsSemantic proximity Read